Our active pharmaceutical ingredients (API) manufacturing facility is US FDA and EU GMP-accredited, with dedicated production blocks for steroids and oncological APIs.
We sustain our leadership position because of a robust approach of backward integration. We manufacture the key raw materials for our products in the API segment, which helps us to sustain our leadership position.
We have some dedicated, world class manufacturing facilities for Xanthine derivatives with a mammoth capacity for its flagship product — Caffeine (3600 MT capacity per annum).
We are also the preferred partner in the regulated markets since we provide regulatory documentation and IPR support for global markets (17 CEPs and 26 USDMFs).